OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources

Highlights from the 2009 Gastrointestinal Cancers Symposium

OncoLink reporters provide in-depth coverage of scientific presentations from the Science and Multidisciplinary Management of GI Malignancies symposium in San Francisco, CA, January 15-17, 2009.

Cetuximab-based neoadjuvant chemoradiation and surgical resection in patients with locally advanced esophageal and gastric cancer
Presenter: H.J. Wanebo, Brown University Oncology Group, Providence, Rhode Island Background Although surgical treatments remain a mainstay of definitive treatments for esophageal and gastric cancers, several groups have demonstrated benefit to...
Effect of extended preoperative chemotherapy on pathologic response and pathologic livery insufficiency after hepatic resection of colorectal liver metastases
Presenter: D. Zorzi, MD Anderson Cancer Center, Houston, TX Background Recent advances in detection and treatment of liver metastasis from colon cancer have resulted in improved outcomes for patients in this disease setting. Most patients are...
Final safety findings from a randomized phase III trial of preoperative FU-based chemoradiation +/- weekly oxaliplatin as neoadjuvant therapy for patients with locally advanced rectal cancer: the STAR (Studio Terapia Adiuvante Retto)-01 randomized trial
Presenter: C. Aschele on behalf of STAR Network Investigators Background Beginning in the mid-1990s, with the publication of results from the German CAO/ARO/AIO 94 trial, a paradigm shift from treatment of locally advanced rectal cancer with...
Relative Outcomes for Asian-Americans with Gastric Adenocarcinoma
Presenter: B.A. Mailey, City of Hope, Duarte, CA Background Reported outcomes for patients with gastric cancer have historically been better in Japan and other Asian countries than in the United States and Europe. These differences have...
Use of endoscopic ultrasonography in screening patients at high-risk for pancreatic cancer
Presenter: J. Poley, University Medical Center, Rotterdam, Netherlands Background Screening of the general population for certain malignancies, including breast cancer, prostate cancer, colon cancer, and cervix cancer has become standard of care...
OncoLink I wish u knew...

Dr. Hill-Kayser talks about working in oncology care and how her line of work can be particularly rewarding. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS